Targeting histone deacetylases (HDACs) and Wee1 for treating high‐risk neuroblastoma

Publisher: John Wiley & Sons Inc

E-ISSN: 1545-5017|62|1|52-59

ISSN: 1545-5009

Source: PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 52-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract